Presentation is loading. Please wait.

Presentation is loading. Please wait.

 Pharmacological prophylaxis in patients with recurrent gout, clinical tophi, or radiological erosiosns. * Contraindications to uricosuric drugs include:

Published byOliver Søndergaard Modified over 6 years ago

Similar presentations

Presentation on theme: " Pharmacological prophylaxis in patients with recurrent gout, clinical tophi, or radiological erosiosns. * Contraindications to uricosuric drugs include:"— Presentation transcript:

1  Pharmacological prophylaxis in patients with recurrent gout, clinical tophi, or radiological erosiosns. * Contraindications to uricosuric drugs include: known urate calculi, renal impairment (creatinine clearance <50 ml/min), 24 hour urinary urate > 800 mg, or previous intolerance.  Pharmacological prophylaxis in patients with recurrent gout, clinical tophi, or radiological erosiosns. * Contraindications to uricosuric drugs include: known urate calculi, renal impairment (creatinine clearance <50 ml/min), 24 hour urinary urate > 800 mg, or previous intolerance. E Suresh Postgrad Med J 2005;81: Copyright © The Fellowship of Postgraduate Medicine. All rights reserved.

Download ppt " Pharmacological prophylaxis in patients with recurrent gout, clinical tophi, or radiological erosiosns. * Contraindications to uricosuric drugs include:"

Similar presentations

TXF-00099 Caveat on urate levels Serum uric acid level may be normal at the time of an acute attack. Normal level does not rule out gout. May be better.

TXF Caveat on urate levels Serum uric acid level may be normal at the time of an acute attack. Normal level does not rule out gout. May be better.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.

Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Drugs in the Body (1) Recurrence Relations A patient is given an initial dose of 50mg of a drug. Each hour the patient is given a 20mg tablet of the.

Drugs in the Body (1) Recurrence Relations A patient is given an initial dose of 50mg of a drug. Each hour the patient is given a 20mg tablet of the.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems

Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
Drug Therapy of Gout 1.

Drug Therapy of Gout 1.
Recent Advancement In Therapeutics ZURAMPIC ( LESINURAD)

Recent Advancement In Therapeutics ZURAMPIC ( LESINURAD)
Lecture 9 Musculoskeletal Disorders Gout

Lecture 9 Musculoskeletal Disorders Gout
Treat to Target in Gout.

Treat to Target in Gout.
Chest radiograph (A) showing confluent infiltrations of the left and right lower lobe. Chest radiograph (A) showing confluent infiltrations of the left.

Chest radiograph (A) showing confluent infiltrations of the left and right lower lobe. Chest radiograph (A) showing confluent infiltrations of the left.
Figure Photomicrograph of the lung biopsy showing a focus of interstitial pneumonitis composed of lymphocytes and macrophages with occasional eosinophils.

Figure Photomicrograph of the lung biopsy showing a focus of interstitial pneumonitis composed of lymphocytes and macrophages with occasional eosinophils.
Chest radiograph of a 60 year old man, with rheumatoid arthritis and progressive dyspnoea, showing signs of fibrosing alveolitis with basal volume loss.

Chest radiograph of a 60 year old man, with rheumatoid arthritis and progressive dyspnoea, showing signs of fibrosing alveolitis with basal volume loss.
(A) Colonic mucosa with inflammation and necrosis (× 40) and (B) at higher magnification (× 100). (A) Colonic mucosa with inflammation and necrosis (×

(A) Colonic mucosa with inflammation and necrosis (× 40) and (B) at higher magnification (× 100). (A) Colonic mucosa with inflammation and necrosis (×
Forest plot of the HRs for DOACs vs warfarin for (A) new or recurrent VTE and (B) major bleeding based on the published subanalyses of the patients with.

Forest plot of the HRs for DOACs vs warfarin for (A) new or recurrent VTE and (B) major bleeding based on the published subanalyses of the patients with.
 Effect of 50 g lactose on breath hydrogen in the three principal genetic groups.  Effect of 50 g lactose on breath hydrogen in the three principal genetic.

 Effect of 50 g lactose on breath hydrogen in the three principal genetic groups.  Effect of 50 g lactose on breath hydrogen in the three principal genetic.
Glial stained section through the midbrain of a patient with PSP showing midbrain atrophy with dilation of the cerebral aqueduct and gliosis of the substantia.

Glial stained section through the midbrain of a patient with PSP showing midbrain atrophy with dilation of the cerebral aqueduct and gliosis of the substantia.
Observed 60 day mortality from ARDS Network clinical Trials from 1997 to 2009. Observed 60 day mortality from ARDS Network clinical Trials from 1997 to.

Observed 60 day mortality from ARDS Network clinical Trials from 1997 to Observed 60 day mortality from ARDS Network clinical Trials from 1997 to.
Suggested algorithm for evaluating a raised ALP (ALP, alkaline phosphatase; ERCP, endoscopic retrograde cholangiopancreatography; GGT, gammaglutamyl transferase;

Suggested algorithm for evaluating a raised ALP (ALP, alkaline phosphatase; ERCP, endoscopic retrograde cholangiopancreatography; GGT, gammaglutamyl transferase;
MRI showing a venous infarct in the parasagittal area on the right and enhancement around the thrombus in the superior sagittal sinus (T1-weighted image.

MRI showing a venous infarct in the parasagittal area on the right and enhancement around the thrombus in the superior sagittal sinus (T1-weighted image.
(A) A patient with anterior acute myocardial infarction with grade II ischaemia. (A) A patient with anterior acute myocardial infarction with grade II.

(A) A patient with anterior acute myocardial infarction with grade II ischaemia. (A) A patient with anterior acute myocardial infarction with grade II.

Similar presentations

Ads by Google